S. Cigolari

3.9k total citations · 1 hit paper
30 papers, 2.3k citations indexed

About

S. Cigolari is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, S. Cigolari has authored 30 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in S. Cigolari's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (11 papers) and Cancer Treatment and Pharmacology (10 papers). S. Cigolari is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (11 papers) and Cancer Treatment and Pharmacology (10 papers). S. Cigolari collaborates with scholars based in Italy, France and Malaysia. S. Cigolari's co-authors include Jean Louis Pujol, D. Brisgand, Jean‐Yves Douillard, Thierry Le Chevalier, Alain Monnier, P. Lianes, P Chomy, Vittorio Gebbia, V. Alberola and A. Riviére and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

S. Cigolari

30 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.

1994 677 citations Thierry Le Chevalier, D. Brisgand et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Cigolari Italy	15	1.8k	1.3k	324	311	269	30	2.3k
Masato Ozaka Japan	21	1.2k 0.7×	581 0.5×	358 1.1×	268 0.9×	188 0.7×	186	1.5k
Timothy R. Asmis Canada	19	758 0.4×	420 0.3×	208 0.6×	212 0.7×	258 1.0×	66	1.3k
Ryan M. Tierney United States	9	1.5k 0.8×	882 0.7×	176 0.5×	819 2.6×	517 1.9×	10	2.1k
Thomas A. Abrams United States	25	1.4k 0.8×	668 0.5×	354 1.1×	306 1.0×	698 2.6×	84	2.4k
Óscar Juan Spain	22	1.4k 0.8×	1.3k 1.0×	378 1.2×	204 0.7×	526 2.0×	154	2.2k
Nadine J. McCleary United States	18	1.2k 0.7×	323 0.3×	196 0.6×	309 1.0×	388 1.4×	75	1.8k
Dwight H. Owen United States	22	1.4k 0.8×	651 0.5×	144 0.4×	313 1.0×	289 1.1×	110	1.9k
J. Philip Kuebler United States	20	1.7k 1.0×	724 0.6×	97 0.3×	449 1.4×	396 1.5×	40	2.1k
Pamela J. Hodul United States	28	2.0k 1.1×	811 0.6×	423 1.3×	743 2.4×	138 0.5×	91	2.3k
Pierre-Luc Etienne France	23	2.3k 1.3×	1.4k 1.1×	168 0.5×	211 0.7×	118 0.4×	72	3.2k

Countries citing papers authored by S. Cigolari

Since Specialization

Citations

This map shows the geographic impact of S. Cigolari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Cigolari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Cigolari more than expected).

Fields of papers citing papers by S. Cigolari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Cigolari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Cigolari. The network helps show where S. Cigolari may publish in the future.

Co-authorship network of co-authors of S. Cigolari

This figure shows the co-authorship network connecting the top 25 collaborators of S. Cigolari. A scholar is included among the top collaborators of S. Cigolari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Cigolari. S. Cigolari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galetta, Domenico, Vittorio Gebbia, Nicola Silvestris, et al.. (2010). Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: A multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603). Lung Cancer. 72(1). 59–63. 11 indexed citations

Galetta, Domenico, Vittorio Gebbia, Francesco Ferraù, et al.. (2009). Activity and tolerability of cisplatin (CDDP) and fotemustine (FTM) in non-small cell lung cancer (NSCLC) patients (PTS) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell’Italia Meridionale (GOIM). Journal of Clinical Oncology. 27(15_suppl). e19085–e19085. 1 indexed citations

Maione, Paolo, Francesco Perrone, Ciro Gallo, et al.. (2005). Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study. Journal of Clinical Oncology. 23(28). 6865–6872. 352 indexed citations

Maïo, Massimo Di, Cesare Gridelli, Ciro Gallo, et al.. (2005). Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials. The Lancet Oncology. 6(9). 669–677. 181 indexed citations

Maïo, Massimo Di, Federica Perrone, Ciro Gallo, et al.. (2003). Supportive care in patients with advanced non-small-cell lung cancer. British Journal of Cancer. 89(6). 1013–1021. 19 indexed citations

Cigolari, S., et al.. (2003). Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study.. PubMed. 23(2C). 1803–9. 8 indexed citations

Gridelli, Cesare, S. Cigolari, Ciro Gallo, et al.. (2001). Activity and toxicity of gemcitabine and gemcitabine+vinorelbine in advanced non-small-cell lung cancer elderly patients. Lung Cancer. 31(2-3). 277–284. 103 indexed citations

Gridelli, Cesare, S. Cigolari, Giovanni Pietro Ianniello, et al.. (2000). Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II study. Lung Cancer. 28(3). 237–244. 6 indexed citations

Gridelli, Cesare, L. Frontini, Federica Perrone, et al.. (2000). Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. British Journal of Cancer. 83(6). 707–714. 51 indexed citations

10.

Maiello, Evaristo, Vittorio Gebbia, Francesco Giuliani, et al.. (2000). 5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group. Annals of Oncology. 11(8). 1045–1052. 27 indexed citations

11.

Maiello, Evaristo, Francesco Giuliani, Vittorio Gebbia, et al.. (1999). Folinic acid (FA) and 5-fluorouracil (FU) alone or with irinotecan (CPT-11) for advanced colorectal cancer (ACC): Preliminary results of a randomized phase II trial. European Journal of Cancer. 35. S71–S71. 1 indexed citations

12.

Gridelli, Cesare, Francesco Perrone, Giovanni Pietro Ianniello, et al.. (1998). Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole.. Journal of Clinical Oncology. 16(4). 1414–1419. 22 indexed citations

13.

Gridelli, Cesare, Franco Perrone, Ciro Gallo, et al.. (1997). Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study. European Journal of Cancer. 33(3). 392–397. 77 indexed citations

14.

Chevalier, Thierry Le, J.L. Pujol, V. Alberola, et al.. (1997). 39 Six year follow up of the European Multicentre Randomised Study comparing Navelbine (NVB) alone vs NVB + Cisplatin (CDDP) vs Vindesine (VDS) + CDDP in 612 patients (pts) with advanced non-small cell lung cancer (NSCLC). Lung Cancer. 18. 13–13. 4 indexed citations

15.

Gridelli, Cesare, Giovanni Pietro Ianniello, L Brancaccio, et al.. (1997). 212 Carboplatin plus vinorelbine: A new active regimen in extensive small cell lung cancer. Results of a multicenter phase II study. Lung Cancer. 18. 55–55. 5 indexed citations

16.

Chevalier, Thierry Le, D. Brisgand, Jean Louis Pujol, et al.. (1996). [Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].. PubMed. 83(5). 385–94. 7 indexed citations

17.

Chevalier, Thierry Le, D. Brisgand, Jean‐Yves Douillard, et al.. (1994). Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.. Journal of Clinical Oncology. 12(2). 360–367. 677 indexed citations breakdown →

18.

Martinelli, Giovanni, et al.. (1990). Gastric lymphoma: diagnosis and follow-up of chemotherapy-induced changes using real-time ultrasonography: a report of three cases. European Journal of Radiology. 11(1). 68–72. 2 indexed citations

19.

Cerini, Raimondo, et al.. (1989). Hepatitis B virus infection among health care workers at an urban teaching hospital in southern Italy: A low occupational hazard?. European Journal of Epidemiology. 5(2). 228–233. 2 indexed citations

20.

Lonardo, Amedeo, et al.. (1984). Lack of correlation between the laboratory findings and a series of steps in the clinical severity of chronic liver disease. La Ricerca in Clinica e in Laboratorio. 14(4). 641–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact